No abstract listed.
Late results of coronary bypass in patients presenting with lower extremity ischemia: the Cleveland Clinic Study
Attrition rate of aorta-to-coronary artery saphenous vein grafts after one year. A study in a consecutive series of 96 patients
Long-term results of femoroinfrapopliteal bypass in diabetic patients with severe ischemia of the lower extremity
Comparison of transcutaneous oximetry, vascular hemodynamic measurements, angiography, and clinical findings to predict the success of peripheral vascular reconstruction
Clinical experience with expanded polytetrafluoroethylene (Gore-Tex) grafts for femoropopliteal arterial bypass
Have the results of infrainguinal bypass improved with the widespread utilisation of postoperative surveillance?
Distal runoff and the development of degenerative changes in autologous reversed saphenous vein femoropopliteal bypass
Transcutaneous oxygen recovery and toe pulse reappearance time in the assessment of peripheral vascular disease
A comparison between two types of waveform analysis in patients with multisegmental arterial disease
Experimental microvascular autogenous vein grafts for arterial defects: II. A histopathologic study of the grafts
Undetected aorto-iliac insufficiency: a reason for early failure of saphenous vein bypass grafts for obstruction of the superficial femoral artery
Experimental microvascular autogenous vein grafts for arterial defects: a study of anastomotic sites
Factors influencing prognosis in the surgery of peripheral vascular disease: platelet adhesiveness, plasma fibrinogen, and fibrinolysis
Pathology of hearts after aortocoronary saphenous vein bypass grafting for coronary artery disease, studied by post-mortem coronary angiography
Intra-operative haemodynamic findings and their prognostic significance in femoropopliteal reversed saphenous vein graft bypass operations
Preliminary report of a new approach to sparing the greater saphenous vein for grafting: valvuloplasty combined with axial transposition of a competent tributary vein
Allogenic & Autologous Therapies
Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.